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Introduction
Parosteal osteosarcoma is a rare low-grade 
bone tumour. It was apparently described 
for the first time in 1951 by Geschickter and 
Copeland, regarding the initial confusion 
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Background. Parosteal osteosarcoma is a rare low-grade bone tumour. The operation material must undergo 
a careful patohistological analysis, because the extent of invasion of the medullar cavity and most pro- 
bably the extent of dedifferentiated areas determines the prognosis and occurrence of local recurrence and 
metastases.
Patients and methods. In this retrospective clinical study, 7 cases of parosteal osteosarcoma of the bone 
have been analyzed. Six patients were with parosteal osteosarcoma and one with periosteal osteosarcoma. 
The study was performed at the Clinic for Orthopedic Surgery in Skopje, Macedonia, from 1995 to 2006. 
This tumour represents 1.5% of all 467 patients with primary bone tumours treated at the Clinic in the 12 
year period. The age of 7 patients (3 female and 4 male) ranged from 8 to 39 years (median 27). The history 
analysis of the patients showed the misinterpreted diagnosis in 57% of the cases, with 71.4 % rate of local 
recurrence, 28.7% of metastases and 28.7% of mortality. The follow-up varied from 7 months to 9 years 
(median 37 months). 
Results. The clinical and histopathological findings of this study (same as those reviewed in the literature) 
confirmed the occurrence of two biologically different types of parosteal osteosarcoma: the predominant 
type is originally “benign” but has a definite malignant potential, causing metastases after the long symp-
tom-free interval. The other type is highly malignant from the beginning. 
Conclusions. The compartmental, radical “en bloc” resection, followed by the regular review of the patients, 
is recommended for the low malignant type, however, the radical surgery, followed by chemotherapy, is 
recommended for the highly malignant tumours.
Key words: osteosarcoma – diagnosis – therapy; periosteum
Received 1 August 2007
Accepted 7 August 2007
Correspondence to: Milan Samardziski MD, MSc, 
University Clinic for Orthopaedic Surgery, University 
“St. Cyril and Methodius”, Vodnjanska 17, 1000 
Skopje, Macedonia; Phone/Fax: + 389 23176 672; 
E-mail: milan_samardziski @ yahoo.com
152_160_Samardziski_Radiology_41152   152 22.10.2007   21:58:27
Samardziski M et al. / Parosteal osteosarcoma 153
Radiol Oncol 2007; 41(3): 152-60.
with the terminology.1,2 It occurs between the 
2nd and 7th decade of life and it represents 1,6 
to 2% of all malignant bone tumours.3 The 
most frequent location is the distal dorsal 
femur. Until clearly proven otherwise, a bone-
forming tumour in this localisation must be 
regarded as parosteal osteosarcoma. To deter-
mine the histopathological diagnosis could be 
“tricky”. The tumour is characterised by hya-
linized fibrous stroma with low cell content 
without substantial nucleus polymorphism 
and variably dense bony trabeculae. The 
operation material must undergo a careful 
patohistological analysis, because the extent 
of invasion of the medullar cavity and most 
probably the extent of dedifferentiated areas 
determines the prognosis and occurrence of 
local recurrence and metastases.4,5
As most authors report, a wide margin of 
excision ensures the adequate surgical treat-
ment of parosteal osteosarcoma in any surgi-
cal grade or stage. No evidence for the devel-
opment of primary tumour satellite nodules 
or of “skip” metastases were seen, so it would 
seem that truly radical or compartmental sur-
gery is rarely indicated. The significant inci-
dence of pulmonary metastasis among those 
patients with Grade III parosteal osteosarco-
ma and involvement of the medullar cavity, 
suggests that, for them, adjuvant chemother-
apy should be considered.3,4,6,7 The primary 
wide excision may be less effective for the lo-
cal recurrence where there has been a previ-
ous inadequate biopsy or surgical treatment, 
because of the contamination and spread of 
the tumour into the surrounding tissues.7
The tumour is most commonly misinter-
preted as osteochondroma or heterotrophic 
ossification and even large institutions have 
limited experience of its diagnosis and man-
agement.4 Parosteal osteosarcoma shows, 
like no other tumour, the necessity of close 
cooperation of all involved disciplines for 
diagnosis and therapy and should be trea-
ted only in specialized institutions for bone 
tumour surgery.
Patients and methods
At the re-examination of the records at the 
Clinic for Orthopedic Surgery in Skopje, 
during the last 12 years (from 1995 to 
2006), 7 cases of juxtracortical osteosar-
coma were found. Five of them were pa-
tients with parosteal osteosarcoma and one 
patient was with periosteal osteosarcoma. 
Parosteal osteosarcoma represented 1.5% 
of all 467 patients with malignant bone tu-
mours treated in this time at the Clinic. 
Reviewing the records, bone scans with 
Technetium 99m, radiographs, arteriography, 
CT, MRI and histopathology findings showed 
6 patients with the confirmed diagnosis of 
parosteal osteosarcoma and one was with a 
high grade chondroblastic type of periosteal 
osteosarcoma. Four of them were diagnosed 
and treated at the Clinic for Orthopedic 
Surgery in Skopje and 3 patients started their 
treatment elsewhere and were misdiagnosed 
for osteochondroma. Another three started 
their treatment as unspecified malignant tu-
mour of distal femur and only one was prima-
rily suspected to be parosteal osteosarcoma.
Results
The clinical details of all 7 patients are sum-
marized in Table 1.
Age and sex 
The age ranged from 8 to 39 years (median 
27). There were 3 female and 4 male pa-
tients.
Site of the tumour 
In 4 cases the site of tumour was the pos-
terior surface of the distal femur. In 1 case 
primary site of tumour was postero-medial 
surface of the proximal femur.  In 1 case the 
site of tumour was proximal humerus and 
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Table 1. Clinical details of the 7 cases
Case /
initials Sex Age Site of  the tumor
Duration of 
symptoms 
(months)
Symptoms Treatment Chemotherapy Local recurrence Metastases
Follow-up
(months)
Outcome
(MSTSS)
1.
VM F 28 Proximal  tibia 13 Painless tumour 1. radical  resection +MMA After Oper.
After 6 
months No 23 25
2.
BT † M 27 Distal  femur 15 Blunt pain and tumour
1. resection 
2. reresection 
3. amputation
After Oper. After 3 months
Lungs after 
23 months 37 
† † 30 
3.
BS † M 8 Distal femur 9 Blunt pain and tumour
1.resection arthrodesis
2. recurrence excision Neo- adjuvant
After 3 
months
Lungs after 
16 months 21 
† † 37 
4.
SV F 39 Distal  femur 17 Painless tumour
1. resection arthrodesis
2. STE. After Oper.
After 32 
months No 71 39
5.
ID M 24 Proximal  femur 13 Painless tumour
1. resection and STE. 
2. disarticulation after masive 
local recurrence
Neo- adjuvant After 61 months No 67 31
6.
JM M 17 Proximal humerus 8
Severe pain tumour and 
reduction of movements
1. radical  resection + 
nonvascular fibular graft No No No 109 33
7.
RM F 32 Distal femur 11 Blunt pain and tumour
1. “en bloc” resection
2. radical resection + STE Neo- adjuvant No No 7 38
median 27 median 13 median 6 19.5 37 33
Legend
MSTSS - Musculoskeletal Tumor Society Score7;
MMA - reconstruction of the defect with metilmet-acrilate (bone cement);
Resection arthrodesis- reconstruction with intramedular nail and MMA;
STE - special tumour endoprosthesis;
† - lethal outcome.
in 1 case the site of tumour was the poste-
rior surface of the proximal tibia.
Symptoms 
The most frequent sign on admission at 
the Clinic was localized painless swelling 
present in 3 patients, progressively increas-
ing blunt pain and swelling was present in 
3 patients and severe “night pain”, swelling 
and restriction of movements was present 
in 1 patient. The duration of the symptoms 
varied from 8 to 17 months (median 13). 
Radiological findings
In 4 cases the radiographs showed a densely 
ossified and lobulated mass on the posterior 
mataphysial cortex of the distal femur (Figure 
1a). Similar dense and lobulated tumours 
were seen at the other sites. Tumours were 
attached to the bone by broad base (Figure 
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1a, 1c). In one case, after the recurrence, two 
thirds of the circumference of the distal femo-
ral metaphysis were involved (Figure 1b). 
This patient was considered to have medullar 
involvement on CT scans (Figure 3a).
Pathological findings 
The tumours were ossified with occasional 
soft areas, all of them infiltrating the 
surrounding soft tissues. Most of them 
had typical histological appearance of a 
low grade parosteal osteosarcoma, with 
spindle cells and collagen fibers embed-
ding osseous trabeculae. The spindle cell 
stroma was scarcely cellular, with low to 
moderate atypia of the cells, as well as 
low mitotic activity. The trabeculae were 
rather regularly arranged, but missing the 
osteoblastic rimming. Two of the cases 
also showed cartilaginous islands in the 
mainly fibroblastic tumour tissue (Figure 
2a). Most of the cases had well (G1) to 
moderate (G2) degree of differentiation 
(Figure 2b). 
Only one presented a high grade chon-
droblastic (G3) surface osteosarcoma. 
It was presented as a high grade sur-
face chondroblastic osteosarcoma (case 
3, Table 1), with scarce and hard to find 
foci of osteoid and wide areas of malig-
nant cartilage. The tumour cells showed 
marked polymorphism and high mitotic 
index (Figure 2c). Recurrent lesions usu-
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Discussion
Parosteal osteosarcoma is a rare malignant 
bone tumour first described by Geschickter 
and Copeland in 1951.1,2,8, 9 Up to date, 
there are reports of parosteal osteosar-
coma even in human pets.10 Larsson and 
Lorentcon found only 206 cases  (includ-
ing sixteen cases from their study) to be 
reported until 1980 in the world litera-
ture.11 The annual incidence in Sweden, as 
they reported, corresponds to one case per 
8 000 000 inhabitants and were accounted 
for about 2% of all primary malignant 
ally showed less differentiation than the 
primary tumours.
Medullar involvement
In 7 patients managed, 1 had the initial 
histological medullar involvement and 2 
patients had the medullar involvement 
after the local recurrence (Figure 3a). For 
two patients who were treated out of the 
Clinic for Orthopaedic Surgery in Skopje 
initially, it was not possible to tell due to 
the lack of evidence (Figure 3b, 3c). Only 
one patient didn’t have the medullar in-
volvement at all (case 6).
Figure 1a. Frontal and lateral radiography of the 
parosteal osteosarcoma of right distal femur (case 2). 
Figure 1b. Frontal and lateral radiography of the 
parosteal osteosarcoma of right distal femur (case 7). 
Figure 1c. X-ray of parosteal osteosarcoma of the right 
proximal humerus (case 6). 
Figure 1d. X-rays of parosteal osteosarcoma of the 
proximal tibia (case 1).
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tumours of bone and 6.2% of all osteosar-
comata. In comparison, Dahlin reported 
that parosteal osteosarcoma constituted 
only 3.7% of all osteosarcomata from Mayo 
Clinic.3,11,12 
Most of the world studies documented 
difficulties in the diagnosis of parosteal os-
teosarcoma. The inability to diagnose the 
lesion correctly often leads to inadequate 
initial operative procedures. The differen-
tial diagnosis may include diverse entities 
such as: myositis ossificans, fracture callus, 
ossifying haematoma, osteochondroma, 
extraosseus osteosarcoma, parosteal chon-
droma, desmoplastic fibroma and osteo-
ma.3,4,5,7,13
The clinical characteristic of patients who 
have a parosteal osteosarcoma is distinctly 
different from that of patients who have 
conventional osteosarcoma.2,13 The most 
common complain was “painless swelling”, 
the same as reviewed in the literature, pre-
sented with 3 patients.3,4,7,8,12 Two of our 
patients had “blunt pain with swelling” and 
one had “night pain”. Most of our patients 
had the symptoms of prolonged duration 
more than one year before admitting at the 
Clinic. 
The site of the parosteal osteosarcoma in 
our study correlates with the reported sites 
of the literature. A predilection for anato-
mic site was a characteristic feature of the 
patients in the study and showed that 50% 
of the patients in our study had the involved 
posterior part of distal metaphysis of the fe-
mur.4,6,9,14, 15
The well described concept of dediffe-
rentiated parosteal osteosarcoma with high-
er incidence of development of metastases 
Figure 2a. Parosteal osteosarcoma showing parallel 
osteoid trabeculae embedded in fibroblastic stroma. 
HE, x100. 
Figure 2b. Focus of a moderate grade of differentiation 
(G2) in a well differentiated osteosarcoma. HE, x200. 
Figure 2c. Osteoid deposits in high grade chondroblastic 
osteosarcoma. HE, x400.
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Figure 3c. Radiograph of the recurrence of parosteal 
osteosarcoma at the proximal femur after limb salvage 
operation with special tumor endoprosthesis (case 5).
Figure 3a. frontal and lateral radiography of  local 
recurrence of “high grade” chondroblastic type 
periosteal osteosarcoma (case 3). 
Figure 3b. CT of distal femur showing the extent of medullar involvement of the bone (case 3). 
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is also applicable in our study.3,5,16,17 The 
dedifferentiation of the tumour showed the 
high incidence with pulmonary metastases 
in one of our patients. A long-term follow 
up is essential for assessing the real malig-
nant potential of parosteal osteosarcoma 
since the recurrence can be considerably 
delayed.18
The results of various types of therapy 
are always difficult to evaluate in retro-
spect. A review of the literature shows that 
the local excision of the tumours has almost 
invariably resulted in recurrence.3,6,9,13,17,18 
The local recurrence was not related to the 
medullar involvement of the tumour but to 
the number or adequacy of biopsies and 
surgical margins of the resection of the 
tumour.14,19 Two of the patients had more 
than one, and one patient had three ina- 
dequate placed biopsies. Further more, 
three of the patients in our study had the 
intralesional or inadequate marginal resec-
tion of the tumour during the primary sur-
gical treatment. Over all results were poor 
to fair and varied from 25 to 39 points of 
MSTS score.20
Conclusions
The findings of this study followed the the-
ory that two distinct types of parosteal oste-
osarcoma exist: one type, which is primarily 
highly malignant and the other one, which 
is originally benign but with the inherent 
malignant potential. Only two patients of 
our study had modern chemotherapy and 
this did not allow any definite conclusion. 
In most of the cases the histopathological 
diagnosis was a problem at the begin-
ning of the treatment. For well delineated 
tumours with a well-differentiated histo-
logical appearance, the radical (en block) 
resection of the tumour and surrounding 
soft tissue is strongly recommended. In 
patients with advanced tumours contain-
ing pleomorphic areas and/or inadequate 
placed biopsies or prior inadequate surgical 
treatment, the amputation should be un-
dertaken. Parosteal osteosarcoma shows, 
like no other tumour, the necessity of the 
close cooperation of all involved disciplines 
for the diagnosis and therapy and should 
be treated only in specialized institutions 
for bone tumour surgery.
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